Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients.

Anticancer research - 1 Jan 2000

Gazouli Maria, Zavos George, Papaconstantinou Ioannis, Lukas John C, Zografidis Anastassios, Boletis John, Kostakis Alkiviadis

Abstract excerpt

BACKGROUND: Kaposi's sarcoma (KS), an angio-proliferative inflammation lesion, is frequently secondary to clinical immunosuppression such as after renal transplantation. KS growth is promoted by the inflammatory cytokine interleukin-6 (IL-6) and is also correlated with human herpesvirus-8 (HHV-8) infection. MATERIALS AND METHODS: In a sample of 15 renal transplant patients with KS and 40 patients without KS, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Herpesvirus 8, Human

Share to Interleukin-6

Share to Kidney Transplantation

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Sarcoma, Kaposi

Source

Identifiers

PMID: 15154666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients.PMID 15154666Read ↗

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.Semantic proximity Read ↗

Association between the interleukin-6 gene polymorphisms and renal cancer risk.Semantic proximity Read ↗

Familial Kaposi's Sarcoma in HHV8 infected subjects presenting the G-174C allele of the IL-6 promoter: a possible role for EBV?Semantic proximity Read ↗

Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosusSemantic proximity Read ↗

Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer.Semantic proximity Read ↗

IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

A meta-analysis of the effects of interleukin-6 -174 G>C genetic polymorphism on acute graft-versus-host disease susceptibility.Semantic proximity Read ↗

Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?Semantic proximity Read ↗

The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.Semantic proximity Read ↗

Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer.Semantic proximity Read ↗

Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.Semantic proximity Read ↗

Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.